Free Trial

GlucoTrack (GCTK) Competitors

GlucoTrack logo
$6.39 -0.32 (-4.77%)
Closing price 04:00 PM Eastern
Extended Trading
$6.40 +0.01 (+0.16%)
As of 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

GCTK vs. NXGL, COCH, IRIX, CTCX, NVNO, DRIO, ALUR, HSDT, NXL, and CODX

Should you be buying GlucoTrack stock or one of its competitors? The main competitors of GlucoTrack include NexGel (NXGL), Envoy Medical (COCH), IRIDEX (IRIX), Carmell (CTCX), enVVeno Medical (NVNO), DarioHealth (DRIO), Allurion Technologies (ALUR), Helius Medical Technologies (HSDT), Nexalin Technology (NXL), and Co-Diagnostics (CODX). These companies are all part of the "medical equipment" industry.

GlucoTrack vs. Its Competitors

GlucoTrack (NASDAQ:GCTK) and NexGel (NASDAQ:NXGL) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their media sentiment, dividends, institutional ownership, profitability, risk, earnings, analyst recommendations and valuation.

10.9% of GlucoTrack shares are held by institutional investors. Comparatively, 2.2% of NexGel shares are held by institutional investors. 12.9% of GlucoTrack shares are held by company insiders. Comparatively, 20.6% of NexGel shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

GlucoTrack has a net margin of 0.00% compared to NexGel's net margin of -25.02%. GlucoTrack's return on equity of 0.00% beat NexGel's return on equity.

Company Net Margins Return on Equity Return on Assets
GlucoTrackN/A N/A -352.05%
NexGel -25.02%-49.37%-25.68%

In the previous week, GlucoTrack and GlucoTrack both had 1 articles in the media. NexGel's average media sentiment score of 1.91 beat GlucoTrack's score of 1.89 indicating that NexGel is being referred to more favorably in the news media.

Company Overall Sentiment
GlucoTrack Very Positive
NexGel Very Positive

GlucoTrack has a beta of -0.17, indicating that its share price is 117% less volatile than the S&P 500. Comparatively, NexGel has a beta of 0.58, indicating that its share price is 42% less volatile than the S&P 500.

NexGel has higher revenue and earnings than GlucoTrack. NexGel is trading at a lower price-to-earnings ratio than GlucoTrack, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
GlucoTrackN/AN/A-$22.60M-$56.60-0.11
NexGel$8.69M2.25-$3.28M-$0.40-6.05

Summary

NexGel beats GlucoTrack on 7 of the 10 factors compared between the two stocks.

Get GlucoTrack News Delivered to You Automatically

Sign up to receive the latest news and ratings for GCTK and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding GCTK and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

GCTK vs. The Competition

MetricGlucoTrackMED PRODUCTS IndustryMedical SectorNASDAQ Exchange
Market Cap$6.03M$10.34B$5.70B$10.42B
Dividend YieldN/A1.93%5.78%4.69%
P/E RatioN/A20.7575.6726.39
Price / SalesN/A28.12540.28125.20
Price / CashN/A24.6425.6730.68
Price / Book-0.013.4012.826.40
Net Income-$22.60M$208.58M$3.29B$276.69M
7 Day Performance4.93%0.74%1.12%-0.28%
1 Month Performance51.42%-2.21%4.54%6.69%
1 Year Performance-99.78%-9.04%68.00%27.61%

GlucoTrack Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
GCTK
GlucoTrack
0.6363 of 5 stars
$6.39
-4.8%
N/A-99.8%$6.03MN/A0.005
NXGL
NexGel
0.766 of 5 stars
$2.47
-2.4%
N/A-7.3%$20.41M$8.69M-6.1710
COCH
Envoy Medical
2.1552 of 5 stars
$0.85
-10.0%
$9.25
+988.1%
-76.2%$20.33M$220K-0.5934Gap Up
High Trading Volume
IRIX
IRIDEX
0.8352 of 5 stars
$1.19
+3.5%
N/A-35.8%$19.54M$49.74M-3.61120
CTCX
Carmell
N/A$0.90
-10.1%
N/A+100.0%$18.76M$32.84K0.0014Gap Down
NVNO
enVVeno Medical
0.8027 of 5 stars
$0.95
+3.5%
N/A-70.1%$17.74MN/A-0.7930
DRIO
DarioHealth
1.4606 of 5 stars
$8.76
+12.6%
$40.00
+356.6%
-37.7%$17.70M$27.15M-0.66200
ALUR
Allurion Technologies
1.3851 of 5 stars
$2.19
-2.5%
$22.83
+945.0%
-86.8%$17.39M$32.11M-0.17501Negative News
HSDT
Helius Medical Technologies
1.3254 of 5 stars
$16.03
+0.1%
N/A-97.3%$17.26M$520K-0.0130News Coverage
NXL
Nexalin Technology
1.9075 of 5 stars
$1.02
+6.3%
$5.00
+390.2%
+32.6%$16.72M$174.81K-1.343
CODX
Co-Diagnostics
4.2649 of 5 stars
$0.40
-4.6%
$5.50
+1,274.7%
-68.8%$16.16M$3.91M-0.35100Positive News
Gap Down

Related Companies and Tools


This page (NASDAQ:GCTK) was last updated on 9/29/2025 by MarketBeat.com Staff
From Our Partners